» Articles » PMID: 25175998

Conducting Multinational, Cross-cultural Research in the Functional Gastrointestinal Disorders: Issues and Recommendations. A Rome Foundation Working Team Report

Overview
Date 2014 Sep 2
PMID 25175998
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cross-cultural, multinational research can advance the field of functional gastrointestinal disorders (FGIDs). Cross-cultural comparative research can make a significant contribution in areas such as epidemiology, genetics, psychosocial modulators, symptom reporting and interpretation, extra-intestinal co-morbidity, diagnosis and treatment, determinants of disease severity, health care utilisation, and health-related quality of life, all issues that can be affected by geographical region, culture, ethnicity and race.

Aims: To identify methodological challenges for cross-cultural, multinational research, and suggest possible solutions.

Methods: This report, which summarises the full report of a working team established by the Rome Foundation that is available on the Internet, reflects an effort by an international committee of FGID clinicians and researchers. It is based on comprehensive literature reviews and expert opinion.

Results: Cross-cultural, multinational research is important and feasible, but has barriers to successful implementation. This report contains recommendations for future research relating to study design, subject recruitment, availability of appropriate study instruments, translation and validation of study instruments, documenting confounders, statistical analyses and reporting of results.

Conclusions: Advances in study design and methodology, as well as cross-cultural research competence, have not matched technological advancements. The development of multinational research networks and cross-cultural research collaboration is still in its early stages. This report is intended to be aspirational rather than prescriptive, so we present recommendations, not guidelines. We aim to raise awareness of these issues and to pose higher standards, but not to discourage investigators from doing what is feasible in any particular setting.

Citing Articles

Translation process of the tested Rome IV diagnostic questionnaire for functional gastrointestinal disorders into Saudi-Arabian Arabic: A mixed-methods approach.

Aljaaly E, Khatib M Pak J Med Sci. 2024; 40(8):1682-1689.

PMID: 39281256 PMC: 11395372. DOI: 10.12669/pjms.40.8.9126.


Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective.

Hidayat A, Waskito L, Sugihartono T, Aftab H, Rezkitha Y, Vilaichone R Intest Res. 2024; 22(3):286-296.

PMID: 38528371 PMC: 11309822. DOI: 10.5217/ir.2023.00199.


Gut microbiota signatures and modulation in irritable bowel syndrome.

Marasco G, Cremon C, Barbaro M, Stanghellini V, Barbara G Microbiome Res Rep. 2023; 1(2):11.

PMID: 38045643 PMC: 10688783. DOI: 10.20517/mrr.2021.12.


Microbiome-immune interactions in tuberculosis.

Mori G, Morrison M, Blumenthal A PLoS Pathog. 2021; 17(4):e1009377.

PMID: 33857251 PMC: 8049499. DOI: 10.1371/journal.ppat.1009377.


Cohort Profile: The Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT).

Heenan P, Creemers R, Sharma S, Keenan J, Bayer S, Young W Inflamm Intest Dis. 2020; 5(3):132-143.

PMID: 32999886 PMC: 7506285. DOI: 10.1159/000508160.